1. Home
  2. HUBC vs BIAF Comparison

HUBC vs BIAF Comparison

Compare HUBC & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
    SELLHOLDBUYas of 7 hours ago
  • BIAF
    SELLHOLDBUYas of 7 hours ago
  • Stock Information
  • Founded
  • HUBC 2017
  • BIAF 2014
  • Country
  • HUBC Israel
  • BIAF United States
  • Employees
  • HUBC N/A
  • BIAF N/A
  • Industry
  • HUBC
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • HUBC
  • BIAF Health Care
  • Exchange
  • HUBC Nasdaq
  • BIAF Nasdaq
  • Market Cap
  • HUBC 15.2M
  • BIAF 14.5M
  • IPO Year
  • HUBC N/A
  • BIAF 2022
  • Fundamental
  • Price
  • HUBC $0.46
  • BIAF $0.97
  • Analyst Decision
  • HUBC
  • BIAF Strong Buy
  • Analyst Count
  • HUBC 0
  • BIAF 1
  • Target Price
  • HUBC N/A
  • BIAF $6.00
  • AVG Volume (30 Days)
  • HUBC 1.0M
  • BIAF 152.2K
  • Earning Date
  • HUBC 12-13-2024
  • BIAF 11-14-2024
  • Dividend Yield
  • HUBC N/A
  • BIAF N/A
  • EPS Growth
  • HUBC N/A
  • BIAF N/A
  • EPS
  • HUBC N/A
  • BIAF N/A
  • Revenue
  • HUBC $33,357,000.00
  • BIAF $9,367,785.00
  • Revenue This Year
  • HUBC N/A
  • BIAF $285.51
  • Revenue Next Year
  • HUBC N/A
  • BIAF $20.05
  • P/E Ratio
  • HUBC N/A
  • BIAF N/A
  • Revenue Growth
  • HUBC N/A
  • BIAF 2813.87
  • 52 Week Low
  • HUBC $0.37
  • BIAF $0.83
  • 52 Week High
  • HUBC $2.48
  • BIAF $3.62
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 47.55
  • BIAF 40.71
  • Support Level
  • HUBC $0.37
  • BIAF $0.83
  • Resistance Level
  • HUBC $0.60
  • BIAF $1.29
  • Average True Range (ATR)
  • HUBC 0.07
  • BIAF 0.13
  • MACD
  • HUBC -0.00
  • BIAF 0.02
  • Stochastic Oscillator
  • HUBC 37.82
  • BIAF 30.92

Stock Price Comparison Chart: HUBC vs BIAF

HUBC
BIAF
AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober0102030405060708090100110120130HUBC VS BIAF

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use